• Latest Posts

Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment

New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients

Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching

Welcome to the Blockbuster Club, Genmab!

This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected

The FDA Approves a Second CAR-T Therapy, Cheaper than Novartis’


Roche Abandons Spanish Cancer Epigenetics Drug

UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic

Interview 22 May 2017

Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

UPDATE: Norwegian Stock Exchange hits Record Biotech IPO

Interview 23 Mar 2017

Meet the CEO of this Intrepid Spanish Biotech exploring Epigenetics